FP-02.2

N/A

Report date: 2024/05/30 20:00:07

Base Information

Drug NameFP-02.2
Drug Alias NameHepsyn-BHepTcellFP-02FP-022FP-02-2 +[6] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesGermany +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAltimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltimmune Inc
Active IndicationsN/A
Inactive IndicationsHepatitis B, ChronicHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A